GENERAL22 Sept 2026
Mankind Pharma shares up 10% in just 4 sessions; Kotak upgrades the stock - Target, share price trend | Stock Market News
Mankind Pharma shares climbed over 2% on Tuesday to ₹2,481, up 10.4% in four sessions even as the Sensex slipped. Kotak upgraded the stock to buy with a ₹3,000 target, citing recovery in the core domestic business. The company also plans to fold in Bharat Serums. If you hold pharma stocks, treat such calls as guidance, not guarantees.
Key Statutory Highlights
- Mankind Pharma shares rose to ₹2,481, gaining 10.4% over four straight sessions even as the Sensex fell about 0.50%.
- Kotak Institutional Equities upgraded the stock to buy from add and raised its target price to ₹3,000 from ₹2,885.
- For the June quarter of FY27, revenue grew 12.9% to ₹4,031 crore and net profit rose 29.1% to ₹574 crore.
Actionable Advice for Taxpayers / Founders:If you hold or are considering this stock, treat the broker upgrade as one opinion only and check your own goals and risk before acting; consider speaking to a certified advisor.
Statutory Disclaimer: TaxQue Shorts are AI-assisted editorial briefs for compliance awareness. This brief has not passed every source check; confirm the original notification before acting. This does not constitute formal legal or CA counsel.
TaxQue News Desk
Share: